📝 Jubilant Ingrevia Limited — results explained
Quarter ended June 2026 (Q1 FY27)
Jubilant Ingrevia Limited reported revenue of ₹1,300 crore for the quarter ended June 2026 (Q1 FY27), up 25.3% from ₹1,038 crore in the same quarter last year, and up 10.3% sequentially over the March 2026 quarter.
Net profit rose 40.9% year-on-year to ₹106 crore, from ₹75 crore. Earnings per share (EPS) came in at ₹6.70.
Operating profit stood at ₹199 crore — an operating margin (OPM) of 15.3%, compared with 13.7% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Jubilant Ingrevia Limited posted revenue of ₹4,389 crore, a growth of 5.1% over FY25, with a net profit of ₹277 crore (up 10.3% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹4,651 crore with a net profit of ₹308 crore.
Valuation snapshot
At the current price of ₹630.95, JUBLINGREA has a market capitalisation of ₹9,951 crore and a trailing P/E of about 32.3.
Within the Chemicals industry, it is the 6th-largest of the 79 companies we track by market value.
Shareholding pattern
As of Mar 2026, promoters held 45.22%, foreign institutional investors (FIIs) 6.49%, domestic institutional investors (DIIs) 24.76%, the government 0.02%, public shareholders 22.53% of Jubilant Ingrevia Limited.